
The NIH on Autoimmune Disease: An Invisible Epidemic
A May 2022 NIH Report on autoimmune research makes clear why the AIID epidemic remains invisible & silent.
A May 2022 NIH Report on autoimmune research makes clear why the AIID epidemic remains invisible & silent.
Back in 2019, pre-Covid pandemic, we already saw attractive investment & business opportunities to meet the large and growing need in autoimmune and chronic immuno-inflammatory diseases. Despite being as prevalent as cancer and growing faster, these diseases remain invisible: under-recognized, under-researched and under-served. In particular, multiple medical specialty silos within
Two types of purifiers: filters and sanitizers There are two types of air purifiers—filters and sanitizers—though some combine both in one product (1). Filters, most effectively, high-efficiency particulate-arresting (HEPA) filters, remove physical particles like dust, pollen, and smoke from the air. This can help alleviate symptoms for people with allergies or
First 2021 post in our series of B2B thought leadership interviews with visionary digital health entrepreneurs working to improve care of chronic conditions. In keeping with our mission, we particularly care about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. Bonnie and Ellen were happy to finally interview digital
The emergence of post-COVID syndrome shines new light on the old problem of post-viral syndromes In Part 1, we discussed how the rise of long covid shines new light on chronic post-viral disorders long ignored by researchers and clinicians. But this issue didn’t just appear with the SARS-COV-2 COVID-19 pandemic.
Will long-COVID activists, especially practitioner-patients, finally force healthcare systems, clinicians and medical researchers to confront post-viral and similar chronic syndromes they have shrugged off for decades? In keeping with our mission, will a focused response by healthcare systems and researchers to post-COVID syndrome help illuminate the invisible epidemic of autoimmune and autoinflammatory disorders?
Dr Bonnie 360 interviews Chase Spurlock, PhD, founder and CEO of Decode Health on AI analytics in COVID and chronic inflammatory disease.
The COVID-19 pandemic and healthcare systems’ responses to it have been the biggest disruptors in digital health’s 30-year history. We hope this will be the biggest disruptor for a few decades to come! Therefore, this is a unique moment of opportunity for digital health. Especially for digital and virtual-first chronic
The COVID-19 pandemic and response is transforming healthcare in many ways, with unpredictable consequences. In fact, the pandemic and healthcare systems’ responses to it are the biggest disruptors in 30 years of digital health. Hopefully, this will be the biggest disruptor for a few decades to come! We see the
On GI practice, beta risk, digital health, VBP and chronic care Another in our new series of B2B thought leadership interviews with visionary entrepreneurs applying digital tools to improve care of chronic immunoinflammatory disorders (CID), including autoimmune and autoinflammatory diseases. We were delighted to speak with Dr Lawrence R. Kosinski,